Christopher Ianelli, M.D., Ph.D., iSpecimen Founder and CEO. “Adding Acutis to the iSpecimen Marketplace ecosystem enables the platform to become even more of a full-service, one-stop-shop for researchers looking to find highly sought-after samples and genetic information for their medical research,” added Dr. “Furthermore, our investment in personnel, technology and other essential resources allows us to provide high-quality, whole genome sequencing to iSpecimen for COVID-19 remnants, tumor samples, and other biospecimens of interest.” “This important initiative between Acutis and iSpecimen highlights our ongoing efforts to advance research in the areas of oncology and COVID-19 today,” said Jibreel Sarij, Acutis CEO. By offering sequencing services for specimens procured on iSpecimen’s platform, researchers can now identify desired samples and receive corresponding sequencing data from a single source instead of vetting and contracting with external sequencing service provider partners. Through the Acutis relationship, iSpecimen will now offer sequencing services to its research community that can help researchers better understand genetic mutations and their impact on diseases such as COVID-19 and cancer.Ĭancer and COVID-19 are currently the second and third leading causes of death in the U.S., respectively. As such, biospecimen samples for these diseases, along with corresponding sequencing data, remain in high demand among researchers who are working on the development of novel diagnostics and therapeutics that could lead to lifesaving medical interventions.
(Nasdaq: ISPC) (“iSpecimen” or the “Company”), a global online biospecimen marketplace that enables life scientists to search across a federated network of healthcare providers for biospecimens needed for medical research, today announced that it added Acutis Diagnostics (“Acutis”), a clinical diagnostics laboratory, to its platform as a laboratory services provider. Some however are lucky enough to move up and they deserve it with all the hard work you have to put up with at this company, Lastly they forced lab techs to work the holidays and only told them ONE WEEK IN ADVANCE and threatened their jobs if they didn't come in.l However not one person in the office had to work the holidays.LEXINGTON, Mass., Ap(GLOBE NEWSWIRE) - iSpecimen Inc. They also promise people they will be moving up in departments just to drag out them working there. They expect certain people to do just about every position with out pay compensation. And then theirs upper management which is the biggest problem. They are willing to go above and beyond to help one another out. The collecting team as in the associates molecular and specimen processors, are also a delight to work for.
However the supervisors are wonderful and do their best to help. The work place is unorganized and irrational. Also be aware the managers have disgusting attitudes toward lab techs, (Molecular and specimen processing). I have never seen such horrible communication in a "well established" company. Something changes everyday and your just expected to know about it there are times the supervisors are unaware of the changes made that day. They act like they care but they honestly could care less about their employees.
0 kommentar(er)
